Position in EVAX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$93,000
-$18,600 QoQ
Shares Held
30,000
0.0% QoQ
Ownership
0.360%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 20 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Annis Gardner Whiting Capital Advisors, LLC holds $3,719,923 across 6 Biotechnology names. EVAX ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
12,801 | $1,014,991 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,953 | $970,113 | |
| 3 | MRNA |
Moderna, Inc.
|
11,813 | $827,264 | |
| 4 | IOVA |
Iovance Biotherapeutics, Inc.
|
100,470 | $417,955 | |
| 5 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
60,000 | $396,600 | |
| 6 | EVAX |
Evaxion A/S
This page
|
30,000 | $93,000 |
All Filings in EVAX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,000 | 30,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $111,600 | 30,000 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||